Valproate Metabolites and Hepatotoxicity in an Epileptic Population

Epilepsia

Volumn 29, Issue 5, 1988, Pages 543-547

  Tennison, Michael B ^a   Miles, Michael V ^a   Pollack, Gary M ^a   Thorn, Michael D ^a   Dupuis, Robert E ^a  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

4 en valproic acid; Anticonvulsants; Drug induced abnormalities; Valproate

Indexed keywords

ANTICONVULSIVE AGENT; VALPROIC ACID;

ADULT; CLINICAL ARTICLE; FATALITY; FEMALE; HISTOLOGY; HUMAN; LIVER TOXICITY; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL;

ADOLESCENT; ADULT; CHILD; CHILD, PRESCHOOL; EPILEPSY; FEMALE; HUMAN; INFANT; LIVER DISEASES; MALE; MIDDLE AGE; VALPROIC ACID;

EID: 0023681736     PISSN: 00139580     EISSN: 15281167     Source Type: Journal    
DOI: 10.1111/j.1528-1157.1988.tb03758.x     Document Type: Article

References (25)

1. Inhibition of medium‐chain fatty acid beta‐oxidation in vitro by valproic acid and its unsaturated metabolite, 2‐n‐propyl‐4‐pentenoic acid
2. Protection against sodium valproate injury in isolated hepatocytes by alpha‐tocopherol and N,N'‐diphenyl‐p‐phenylenediamine
3. Action of the antiepileptic drug, valproic acid, on fatty acid oxidation in isolated rat hepatocytes
4. Pharmacology of valproic acid in children with epilepsy: clearance and hepatotoxicity
5. Valproic acid hepatic fatalities: a retrospective review
6. The hepato‐toxicity of valproic acid and its metabolites in rats. II. Intermediary and valproic acid metabolism
7. Sodium valproate and routine liver function tests [editorial]
8. Oxidation and glucuronidation of valproic acid in male rats–Influence of phenobarbitol, 3‐methylchloranthrene, (3‐naphthoflavone and clofibrate
9. Non‐dose‐related side effects of valproate
10. The hepatotoxicity of valproic acid and its metabolites in rats. I. Toxicologic, biochemical and histopathologic studies
11. Abnormal metabolism of valproic acid in fatal hepatic failure
12. Valproate‐induced hepatic steatogenesis in rats
13. Concentration of metabolites of valproic acid in plasma of epileptic patients
14. Biotransformation and pharmacokinetics in the rhesus monkey of 2‐n‐propyl‐4‐pentenoic acid, a toxic metabolite of valproic acid
15. Metabolic fate of valproic acid in the rhesus monkey. Formation of a toxic metabolite, 2‐n‐propyl‐4‐pentenoic acid
16. Studies on the biotransformation in the perfused rat liver of 2‐n‐propyl‐4‐pentenoic acid, a metabolite of the antiepileptic drug valproic acid. Evidence for the formation of chemically reactive intermediates
17. Cytochrome P‐450–catalyzed formation of delta 4‐VPA, a toxic metabolite of valproic acid
18. Valproate hepatotoxicity [letter]
19. Acute hepatic failure with the use of sodium valproate
20. Hepatotoxicity in rat following administration of valproic acid
21. The effects of valproate on intermediary metabolism in isolated rat hepatdcytes and intact rats
22. Sodium valproate‐induced hyperammonemia without clinical hepatic dysfunction
23. Valproate‐induced hepatic injury: analyses of 23 fatal cases